Literature DB >> 20225085

Revision of vagal nerve stimulation (VNS) electrodes: review and report on use of ultra-sharp monopolar tip.

Wai Hoe Ng1, Elizabeth Donner, Cristina Go, Amal Abou-Hamden, James T Rutka.   

Abstract

PURPOSE: As a result of the increasingly popularity of vagal nerve stimulation (VNS) for intractable seizures, neurosurgeons not uncommonly encounter cases which require electrode revision. We examine our experience of VNS revision and reports the use of the ultra-sharp monopolar tip for safe dissection and removal of the electrode from the vagus nerve.
METHODS: A retrospective review was performed from January 2000 to Dec 2009 reviewed eight cases of VNS revision.
RESULTS: The indications for VNS revision were device malfunction manifesting with increased seizures or increased impedance of the device and infection. The time from initial VNS implantation to revision ranged from 6 to 108 months (mean: 38 months). The entire VNS electrode system, was removed in seven cases and the helical coils were left in-situ in one case who did not derive any benefit from VNS and it was deemed unnecessary to subject the patient to the additional risk of vagal nerve injury. One case had dislodgement of the lower two coils and three cases had dense scarring to the vagus nerve causing high impedance and malfunction. The other three cases demonstrated no fibrotic scar tissue between the helical coils and the vagus nerve. Four cases had replacement of new VNS system but the case of infected VNS stimulator was not replaced as there was no benefit from the device.
CONCLUSION: VNS revision is normally performed in cases of device malfunction or infection and can be safely performed using a combination of ultra-sharp monopolar coagulation and sharp dissection.

Entities:  

Mesh:

Year:  2010        PMID: 20225085     DOI: 10.1007/s00381-010-1121-2

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  15 in total

Review 1.  Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children.

Authors:  Mony Benifla; James T Rutka; William Logan; Elizabeth J Donner
Journal:  Childs Nerv Syst       Date:  2006-07-01       Impact factor: 1.475

2.  Deep wound infection after vagus nerve stimulator implantation: treatment without removal of the device.

Authors:  M Ortler; G Luef; A Kofler; G Bauer; K Twerdy
Journal:  Epilepsia       Date:  2001-01       Impact factor: 5.864

3.  Efficacy and safety of vagus nerve stimulation in patients with complex partial seizures.

Authors:  B M Uthman; B J Wilder; E J Hammond; S A Reid
Journal:  Epilepsia       Date:  1990       Impact factor: 5.864

4.  Right-sided vagus nerve stimulation as a treatment for refractory epilepsy in humans.

Authors:  Amy McGregor; James Wheless; James Baumgartner; David Bettis
Journal:  Epilepsia       Date:  2005-01       Impact factor: 5.864

5.  Vagal nerve stimulator pocket infections.

Authors:  Niraj C Patel; Morven S Edwards
Journal:  Pediatr Infect Dis J       Date:  2004-07       Impact factor: 2.129

6.  Treatment of epilepsy by stimulation of the vagus nerve.

Authors:  B M Uthman; B J Wilder; J K Penry; C Dean; R E Ramsay; S A Reid; E J Hammond; W B Tarver; J F Wernicke
Journal:  Neurology       Date:  1993-07       Impact factor: 9.910

Review 7.  An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome.

Authors:  A P Amar; C N Heck; M L Levy; T Smith; C M DeGiorgio; S Oviedo; M L Apuzzo
Journal:  Neurosurgery       Date:  1998-12       Impact factor: 4.654

8.  Cervical spinal MRI in a patient with a vagus nerve stimulator (VNS).

Authors:  Robert Roebling; Klaus Huch; Jan Kassubek; Holger Lerche; Yvonne Weber
Journal:  Epilepsy Res       Date:  2009-03-09       Impact factor: 3.045

9.  Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group.

Authors:  E Ben-Menachem; R Mañon-Espaillat; R Ristanovic; B J Wilder; H Stefan; W Mirza; W B Tarver; J F Wernicke
Journal:  Epilepsia       Date:  1994 May-Jun       Impact factor: 5.864

10.  Revision of vagal nerve stimulator electrodes: technical approach.

Authors:  J MacDonald; W T Couldwell
Journal:  Acta Neurochir (Wien)       Date:  2004-04-18       Impact factor: 2.216

View more
  6 in total

1.  High lead impedances requiring revision during vagal nerve stimulator generator replacement.

Authors:  Pouya Entezami; John W German; Matthew A Adamo
Journal:  Acta Neurochir (Wien)       Date:  2020-09-24       Impact factor: 2.216

2.  Biomechanical and functional variation in rat sciatic nerve following cuff electrode implantation.

Authors:  Stephen M Restaino; Erkinay Abliz; Kelliann Wachrathit; Victor Krauthamer; Sameer B Shah
Journal:  J Neuroeng Rehabil       Date:  2014-04-23       Impact factor: 4.262

3.  Surgical revision after Vagus Nerve Stimulation. A case series.

Authors:  Philipp Spindler; Peter Vajkoczy; Ulf Christoph Schneider
Journal:  Epilepsy Behav Rep       Date:  2021-03-26

Review 4.  Vagus nerve stimulation lead removal or replacement: surgical technique, institutional experience, and literature overview.

Authors:  Marlien W Aalbers; Kim Rijkers; Sylvia Klinkenberg; Marian Majoie; Erwin M J Cornips
Journal:  Acta Neurochir (Wien)       Date:  2015-09-03       Impact factor: 2.216

Review 5.  Vagus Nerve Stimulation (VNS) and Other Augmentation Strategies for Therapy-Resistant Depression (TRD): Review of the Evidence and Clinical Advice for Use.

Authors:  Helge H O Müller; Sebastian Moeller; Caroline Lücke; Alexandra P Lam; Niclas Braun; Alexandra Philipsen
Journal:  Front Neurosci       Date:  2018-04-10       Impact factor: 4.677

6.  Use of Polyvinyl Alcohol Sponge Cubes for Vagal Nerve Stimulation: A Suggestion for the Wrapping Step. Technical Note and Step-by-Step Operative Technique.

Authors:  Hussein Hamdi; Giorgio Spatola; Stanislas Lagarde; Aileen McGonigal; Armando Paz-Paredes; Alain Bizeau; Fabrice Bartolomei; Romain Carron
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-05-01       Impact factor: 2.703

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.